Haemonetics (HAE) Tops Q1 EPS by 2c
Tweet
Share
E-mailGet Alerts HAE Hot Sheet
Price: $108.40 +0.74%
EPS Growth %: +1.6%
Financial Fact:
Income before provision for income taxes: 22.83M
Today's EPS Names:
VIVO, OCCI, ALZN, More
EPS Growth %: +1.6%
Financial Fact:
Income before provision for income taxes: 22.83M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
Haemonetics (NYSE: HAE) reported Q1 EPS of $0.33, $0.02 better than the analyst estimate of $0.31. Revenue for the quarter came in at $211 million versus the consensus estimate of $212.12 million.
For earnings history and earnings-related data on Haemonetics (HAE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citi upgrades Haemonetics to Buy, raises price target to $123
- UBS Reiterates Neutral Rating on Intuit (INTU), Says Investor Day Not 'Sentiment-Changing'
- Vera Bradley (VRA) Tops Q2 EPS by 10c ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
